Notably, when T-ALL cells were cultured in vitro and transformed into MHC class I-low/negative tumor cells, LMP1/2A-activated CD8+ T cells still demonstrated effective cytotoxicity against these tumor cells. This evidence concerns the gene PDLIM7 and acute lymphoblastic leukemia.